VIRTUAL EVENT
Targets the industry’s translational challenges in targeting both rare and common ophthalmic disorders including wet AMD, dry AMD, DME, IRDs and more.
Back to All Events
Earlier Event: September 20
Cell & Gene Therapy Manufacturing & Commercialization US
Later Event: September 21
Formulation & Delivery UK